# A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine

> **NCT04102995** · PHASE2 · COMPLETED · sponsor: **Asarina Pharma** · enrollment: 86 (actual)

## Conditions studied

- Menstrual Migraine

## Interventions

- **DRUG:** Sepranolone injection low dose
- **DRUG:** Sepranolone injection high dose
- **DRUG:** Placebo injection

## Key facts

- **NCT ID:** NCT04102995
- **Lead sponsor:** Asarina Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-27
- **Primary completion:** 2021-05-15
- **Final completion:** 2021-05-15
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2021-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04102995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04102995, "A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04102995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*